| Browse All

ProShares UltraShort Nasdaq Biotechnology (BIS)

Trading--Inverse Equity | Exchange Traded Fund | NasdaqGM
7.98 USD -0.27 (-3.333%) ⇩ (April 17, 2026, 4 p.m. EDT)
After hours: 7.98 0.00 (-0.003%) ⇩ (April 17, 2026, 4:10 p.m. EDT)

Short-term: ★☆☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ★★★★☆
Hot Take | April 11, 2026, 3:24 p.m. EDT

BIS is a leveraged inverse ETF that tracks the Nasdaq Biotechnology index, making it a volatile instrument. The recent price action shows a downward trend, with the price currently near its 52-week low. While the dividend yield is high, the stock's price performance has been weak, and the options market is not indicating strong momentum. Investors should be cautious due to the leveraged nature of the ETF and the lack of clear directional signals from the options market.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoETS ✓0.040242
AutoARIMA0.040242
MSTL0.041898
AutoTheta0.068065

Forecast horizon: 45 days | Selected: AutoETS

Forecast Reliability
Score 48%
H-stat 5.24
Ljung-Box p 0.000
Jarque-Bera p 0.273
Excess Kurtosis -0.08

As of April 11, 2026, 3:24 p.m. EDT: The options data suggests limited activity and low implied volatility across expirations. For the near-term expirations, there is minimal open interest and volume, indicating low speculative activity. The presence of ATM anchor puts on the 2026-11-20 expiration suggests some short-term bearish sentiment, but the low volume and open interest indicate limited conviction. Overall, the options market is not providing strong signals about future price direction, suggesting a lack of consensus among speculators.


Dividend Data

Yield Summary
Last Yield 1yr Yield 3yr Avg 5yr Avg
0.75% 3.68% 3.46% 2.07%
Dividend History
Date Dividend Yield %
2026-03-25 0.069 0.748373
2025-12-24 0.103 1.151280
2025-09-24 0.154 1.154922
2025-06-25 0.108 0.630276
2025-03-26 0.133 0.777481
2024-12-23 0.206 1.214195
2024-09-25 0.152 1.034580
2024-06-26 0.161 1.040512
2024-03-20 0.159 0.962677
2023-12-20 0.176 0.942185
2023-09-20 0.119 0.597852
2023-06-21 0.021 0.117611
2020-03-25 0.104 0.178921
2019-12-24 0.164 0.354363
2019-09-25 0.324 0.471889
2019-06-25 0.384 0.603825
2019-03-20 0.256 0.437845
2018-12-26 0.272 0.321036
2018-09-26 0.072 0.127122
Additional Data
trailingAnnualDividendRate 0.0
trailingAnnualDividendYield 0.0
dividendYield 4.92

Info Dump

Attribute Value
All Time High 6,849.6
All Time Low 7.95
Ask 8.06
Ask Size 1
Average Daily Volume10 Day 13,920
Average Daily Volume3 Month 15,412
Average Volume 15,412
Average Volume10Days 13,920
Beta3 Year -1.45
Bid 7.97
Bid Size 1
Category Trading--Inverse Equity
Crypto Tradeable 0
Currency USD
Custom Price Alert Confidence HIGH
Day High 8.15
Day Low 7.95
Dividend Yield 4.92
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 8.8448
Fifty Day Average Change -0.8678999
Fifty Day Average Change Percent -0.09812544
Fifty Two Week Change Percent -61.836445
Fifty Two Week High 21.24
Fifty Two Week High Change -13.2631
Fifty Two Week High Change Percent -0.6244397
Fifty Two Week Low 7.95
Fifty Two Week Low Change 0.026900291
Fifty Two Week Low Change Percent 0.0033836844
Fifty Two Week Range 7.95 - 21.24
First Trade Date Milliseconds 1,270,819,800,000
Five Year Average Return -0.1638158
Full Exchange Name NasdaqGM
Fund Family ProShares
Fund Inception Date 1,270,512,000
Gmt Off Set Milliseconds -14,400,000
Has Pre Post Market Data 1
Language en-US
Legal Type Exchange Traded Fund
Long Business Summary The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain inverse leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.
Long Name ProShares UltraShort Nasdaq Biotechnology
Market us_market
Market State CLOSED
Max Age 86,400
Message Board Id finmb_100661536
Nav Price 7.9821
Net Assets 2,475,569.0
Net Expense Ratio 0.95
Open 8.15
Post Market Change -0.0029997826
Post Market Change Percent -0.037591733
Post Market Price 7.9769
Post Market Time 1,776,456,604
Previous Close 8.2519
Price Hint 2
Quote Source Name Nasdaq Real Time Price
Quote Type ETF
Region US
Regular Market Change -0.27499962
Regular Market Change Percent -3.3325613
Regular Market Day High 8.15
Regular Market Day Low 7.95
Regular Market Day Range 7.95 - 8.15
Regular Market Open 8.15
Regular Market Previous Close 8.2519
Regular Market Price 7.9769
Regular Market Time 1,776,456,000
Regular Market Volume 15,627
Short Name ProShares UltraShort Nasdaq Bio
Source Interval 15
Symbol BIS
Three Year Average Return -0.22700399
Total Assets 2,475,569
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Peg Ratio None
Trailing Three Month Nav Returns -6.30763
Trailing Three Month Returns -6.30763
Triggerable 1
Two Hundred Day Average 11.29375
Two Hundred Day Average Change -3.3168497
Two Hundred Day Average Change Percent -0.29368895
Type Disp ETF
Volume 15,627
Yield 0.049200002
Ytd Return -6.30763